Please login to the form below

Not currently logged in
Email:
Password:

InterComm International under new management

Malcolm Allison and Ben Greeves take over the med comms agency

InterComm InternationalMedical communications agency InterComm International has changed ownership, with Malcolm Allison and Ben Greeves acquiring the firm.

Based in Cambridge, UK, InterComm had been under the leadership of chief executive Martin Lancaster and managing director David Mercer since 1998.

Allison and Greeves took over the reins in September as director and general manager respectively, working to deliver multichannel campaigns in the pharmaceutical and healthcare arena.

Outlining the agency's focus, Greeves told PMLiVE: “We want to be known for delivering excellence with integrity.

“We have a great team with experience across many different clients, covering assets including medical devices, pharmaceuticals, animal health and consumer brands.”

Greeves first joined InterComm six years ago after establishing his own digital solutions firm, while Allison brings over 30 years of pharmaceutical marketing experience to the agency.

With strategic and tactical marketing and sales experience accrued while at Actelion, Bayer, GlaxoSmithKline, Novartis and Pfizer, Allison described his agency-side move as “a natural progression”.

He told PMLiVE: “We want to help clients tell their story. As InterComm moves forward under new management, we will continue working in this fast-paced industry, delivering materials that excite, educate and inform.”

Article by
Rebecca Clifford

8th December 2016

From: Marketing

Share

Tags

COVID-19 Updates and Daily News

Featured jobs

PMHub

Add my company
Aptus Health

Aptus Health is dedicated to advancing health engagement. The company offers end-to-end digital health engagement solutions spanning all areas of...

Latest intelligence

Delivering true value: what does it mean for KAM in cancer care?
Lisa Alderson, Business Development Director at Wilmington Healthcare, explores the challenges that pharma’s KAM teams face in engaging with the NHS and how they must evolve...
Pharma M&A
Pharma funding and M&A in 2020
Why pharma M&A has continually bucked the trend...
Behaviour change through medical education: How can we turn aspiration into reality?
Practical, evidence-based insights into a CME process that aims to effect measurable behaviour change...

Infographics